These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26395151)

  • 21. Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis.
    Gonzalo X; Casali N; Broda A; Pardieu C; Drobniewski F
    Int J Antimicrob Agents; 2015 Apr; 45(4):406-12. PubMed ID: 25717028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
    Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
    Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
    Winchell CG; Mishra BB; Phuah JY; Saqib M; Nelson SJ; Maiello P; Causgrove CM; Ameel CL; Stein B; Borish HJ; White AG; Klein EC; Zimmerman MD; Dartois V; Lin PL; Sassetti CM; Flynn JL
    Front Immunol; 2020; 11():891. PubMed ID: 32477361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance
    Guo Y; Yang J; Wang W; Wu X; Wan B; Wang H; Sha W; Yu F
    Infect Drug Resist; 2023; 16():7587-7595. PubMed ID: 38107433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Horgen L; Barrow WW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):149-57. PubMed ID: 9685005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.
    Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK
    Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Zhang D; Wang Y; Lu J; Pang Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
    Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.
    Rey-Jurado E; Tudó G; de la Bellacasa JP; Espasa M; González-Martín J
    Int J Antimicrob Agents; 2013 Mar; 41(3):278-80. PubMed ID: 23312604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
    Yang M; Zhan S; Fu L; Wang Y; Zhang P; Deng G
    Drug Discov Ther; 2022 May; 16(2):99-101. PubMed ID: 35418550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.
    Pieterman ED; Te Brake LHM; de Knegt GJ; van der Meijden A; Alffenaar JC; Bax HI; Aarnoutse RE; de Steenwinkel JEM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.
    Kim S; Louie A; Drusano GL; Almoslem M; Kim S; Myrick J; Nole J; Duncanson B; Peloquin CA; Scanga CA; Yamada W; Neely M; Schmidt S
    Int J Antimicrob Agents; 2022 Feb; 59(2):106509. PubMed ID: 34958863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.
    de Knegt GJ; van der Meijden A; de Vogel CP; Aarnoutse RE; de Steenwinkel JE
    Int J Antimicrob Agents; 2017 Mar; 49(3):302-307. PubMed ID: 28162983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid resistance in
    Nambiar R; Tornheim JA; Diricks M; De Bruyne K; Sadani M; Shetty A; Rodrigues C
    Indian J Med Res; 2021 Jul; 154(1):85-89. PubMed ID: 34782533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
    Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linezolid in the treatment of extensively drug-resistant tuberculosis.
    Zhang L; Pang Y; Yu X; Wang Y; Gao M; Huang H; Zhao Y
    Infection; 2014 Aug; 42(4):705-11. PubMed ID: 24902521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice.
    Yu W; Chiwala G; Gao Y; Liu Z; Sapkota S; Lu Z; Guo L; Khan SA; Zhong N; Zhang T
    Biomed Pharmacother; 2020 Nov; 131():110782. PubMed ID: 33152940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.